CareLive · The Longitudinal Health Platform
CareLive carries important chronic issues related biomarkers, stages every person's cardiovascular–kidney–metabolic (CKM) health from 0 to 4 — catching risk in the pre-disease window, connecting clinically validated devices, and giving individuals and organisations one living picture of health.








Why CKM — Why Now
Cardiovascular, kidney and metabolic diseases are one connected system — and its earliest signals appear long before any single condition is diagnosed. The CKM framework, defined by the American Heart Association in 2023 and now endorsed in China's first CKM expert consensus (2026), gives us a common scale to measure that hidden risk: Stage 0 to Stage 4.
Stages 0–2 are where outcomes are still changeable. Excess weight, rising blood pressure, early metabolic drift — these are not yet diseases, but they are measurable, trackable, and reversible with the right engagement. CareLive exists to work precisely here: turning silent risk into visible, actionable health trajectories — for one person, or for ten thousand.
Security & Compliance
Get Started
Book a demo for your organisation — or join as an individual. We reply within two business days.
Book a demo